Optimization of approaches to the treatment of metastatic colorectal cancer wild-type gene KRAS
Journal Title: JOURNAL OF HEALTH POLICY & OUTCOMES RESEARCH - Year 2015, Vol 8, Issue 2
Abstract
The results of the literature review of drug use for the treatment of metastatic colorectal cancer (mCRC) are presented. Analysis of the data showed that cetuximab (Erbitux) and panitumumab (Vectibix) are effective drugs for mCRC patients with KRAS wild-type in the first-line therapy, and the combination of standard chemotherapy regimen FOLFOX in combination with targeted therapy cetuximab (Erbitux) is the most optimal medical technology as compared with other combinations of chemotherapy and targeted drugs.
Authors and Affiliations
Malwina Hołownia, Ekaterina Bashlakova, Ilya Solodun, Evgenyi Evdoshenko
Keywords
Related Articles
- EP ID EP192168
- DOI 10.7365/JHPOR.2015.2.7
- Views 123
- Downloads 0
The assessment of the impact of thrombocytopenia symptoms on the patients’ daily activities with the use of TSIDAV vignette
Objective: Assessment of the impact of thrombocytopenia symptoms on patients’ daily activities using vignettes. Methods: Vignettes were used to collect information from adult patients and children’s caregivers in order...
Contracts for providing publically funded outpatient medical services - criteria for tenders evaluation as a tool of health policy in Poland
he Polish health care system is essentially divided into three basic levels of service: basic health care, outpatient specialist care, hospital treatment. Since 2003 the payer is the National Health Fund. Medical facilit...
Pharmaceutical Policies under Economic Crisis: The Greek case
Introduction: The purpose of this paper is to critically assess the Pharmaceutical reforms implemented in Greece before and during the economic crisis. The effects of the crisis are multiple in terms of GDP reduction, se...
Cost-utility analysis and budget impact analysis of pegvisomant for the treatment of adult patients with acromegaly in Poland
Background: The aim of this publication was to evaluate the cost-effectiveness and financial consequences of pegvisomant (PEG) in the treatment of adult patients with acromegaly, who have had an inadequate response to su...
Cost-effectiveness analysis of methods of diagnosis of tb infection in russian regions by use of recombinant tb allergen in children and adolescents
Background. Russia is among the countries with a high burden of TB. A new diagnostic method for TB has been developed, called ‘recombinant tuberculosis allergen’ or RTA (Diaskintest®), which has a similar cost and method...